Exkivity 40mg Capsules: A Game-Changer for NSCLC with EGFR Exon 20 Insertion Mutation?
I've been reading about Exkivity (Mobocertinib) 40mg Capsules, a new treatment option for non-small cell lung cancer (NSCLC) with an EGFR Exon 20 insertion mutation. It's promised to block signals that help cancer cells grow, but I've also seen some alarming side effects listed. Has anyone here had experience with this medication? I'd love to hear about both the positive and negative aspects. How does it compare to other treatments? What should I be most concerned about?
lungcancer
onkology
cancerTreatmentReviews
james_morrison · 2d ago1 min read
last active 2d ago
HOT